AMGXF
Price:
$0.3602
Market Cap:
$25.48B
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and disc degeneration; medical devices for the prevention of vascular restenosis; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative r...[Read more]
Industry
Biotechnology
IPO Date
2017-07-03
Stock Exchange
OTC
Ticker
AMGXF
According to AnGes, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 22.77B. This represents a change of 45.16% compared to the average of 15.69B of the last 4 quarters.
The mean historical Enterprise Value of AnGes, Inc. over the last ten years is 35.98B. The current 22.77B Enterprise Value has changed 6.23% with respect to the historical average. Over the past ten years (40 quarters), AMGXF's Enterprise Value was at its highest in in the June 2020 quarter at 226.71B. The Enterprise Value was at its lowest in in the September 2015 quarter at 7.60B.
Average
35.98B
Median
20.32B
Minimum
9.16B
Maximum
136.81B
Discovering the peaks and valleys of AnGes, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 209.74%
Maximum Annual Enterprise Value = 136.81B
Minimum Annual Increase = -76.30%
Minimum Annual Enterprise Value = 9.16B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 11.04B | 12.28% |
| 2023 | 9.83B | 7.33% |
| 2022 | 9.16B | -76.30% |
| 2021 | 38.65B | -71.75% |
| 2020 | 136.81B | 140.51% |
| 2019 | 56.88B | 120.64% |
| 2018 | 25.78B | -44.01% |
| 2017 | 46.04B | 209.74% |
| 2016 | 14.87B | 38.77% |
| 2015 | 10.71B | 32.34% |
The current Enterprise Value of AnGes, Inc. (AMGXF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.01B
5-year avg
41.10B
10-year avg
35.98B
AnGes, Inc.’s Enterprise Value is greater than Faron Pharmaceuticals Oy (252.38M), greater than Adocia S.A. (140.80M), greater than Recce Pharmaceuticals Ltd (178.17M), greater than Planet 13 Holdings Inc. (102.72M), greater than Newron Pharmaceuticals S.p.A. (421.53M), greater than Volpara Health Technologies Limited (284.13M), greater than Ascentage Pharma Group International (20.23B), greater than Eupraxia Pharmaceuticals Inc. (187.98M), greater than EKF Diagnostics Holdings plc (95.43M), less than Prescient Therapeutics Limited (0),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 252.38M | $209.54M | |
| 140.80M | $170.44M | |
| 178.17M | $76.55M | |
| 102.72M | $202.02M | |
| 421.53M | $239.53M | |
| 284.13M | $188.24M | |
| 20.23B | $127.31M | |
| 187.98M | $108.29M | |
| 95.43M | $179.63M | |
| 0 | $117.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AnGes, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AnGes, Inc. (AMGXF)?
What is the 3-year average Enterprise Value for AnGes, Inc. (AMGXF)?
What is the 5-year average Enterprise Value for AnGes, Inc. (AMGXF)?
How does the current Enterprise Value for AnGes, Inc. (AMGXF) compare to its historical average?